qEV ISOLATION PLATFORM

Higher-Purity Extracellular Vesicle Isolation. Built to Scale.

The qEV Isolation platform sets the standard for EV purification – now extended to LNPs and beyond, with the precision, scalability and bioprocessing expertise your application demands.

Unmatched separation

Our exclusive resin and carefully optimised qEV columns deliver highly pure isolates.

Quality that scales

Process 150 µL through to thousands of litres, with a level of quality that is maintained with increased throughput.

Backed by deep expertise

Draw on 30+ years of bioprocessing experience to fast-track your isolation workflow development.

Gentle, Size-Based Separation – Built for EVs

qEV columns isolate extracellular vesicles by size exclusion chromatography (SEC). As your sample flows through the porous resin, larger particles like EVs pass around the beads and elute first, while proteins detour through the small resin pores and trail behind.

Particles stay intact, as separation is achieved gently under gravity, without high centrifugal or shear forces.

From EVs and exosomes to LNPs, the qEV platform supports a range of particle sizes and sample volumes.

qEV elution profile: EV particle concentration and protein across the elution volumeEV particle concentration against elution volume, with the proportion of loaded protein on the right-hand axis. The shaded band marks the purified collection volume, where EVs elute ahead of the bulk of the protein.
EVs elute early and cleanly ahead of the protein peak, as measured by TRPS and BCA assay.

More Than Your Average SEC Column

The exclusive Gen 2 resin used in qEV columns has been optimised for superior EV-protein separation and maximal purity. Alongside that, column manufacturing has been refined for greater consistency and quality. That translates to:

  • Unmatched plasma EV purification
  • Purified isolates derived from cell culture media, milk, CSF, urine and more
  • Removal of unbound labels and other impurities, alongside significant lipoprotein removal
  • cGMP-ready columns available on request
EV purity: qEV Gen 2 columns vs comparable SEC resinsEVs and similarly sized particles above 60 nm recovered per microgram of protein, for qEV Gen 2 35 nm and 70 nm columns against CL-4B and CL-2B resins.
Higher EV purity than comparable SEC columns.

Maximum Purity or Maximum Recovery? Your Choice.

Distinguished by the pore size of the resin used – 20 nm, 35 nm, and 70 nm – each produces isolates with distinct characteristics.

MAXIMUM RECOVERY

MAXIMUM PURITY

20nm

PORE-SIZE SERIES

Optimum range 20–100 nm.
Reaches sub-50 nm particles like exomeres and small viruses.

Purity

Moderate

Recovery

Highest

35nm

PORE-SIZE SERIES

Optimum range 35–400 nm.
The balanced default, popular for cell-culture EVs.

Purity

High

Recovery

High

70nm

PORE-SIZE SERIES

Optimum range 70–2000 nm.
Highest lipoprotein depletion, ideal for plasma EV biomarkers.

Purity

Highest

Recovery

Moderate

Compare the full qEV series

Fast-Track Development With Expert Support at Every Stage

We've done the groundwork, so you don't have to. Our isolation refinement expertise – including single-particle measurement capabilities for assessing elution profiles – gives your workflow development a major headstart.

As your needs evolve, our bioprocessing team is ready to support you, whether through customised GMP-ready solutions, pilot studies for refining SEC-TFF workflows, or beyond.

Laboratory fluid control system with touchscreen interface, tubing, and a bottle on a digital scale labeled Mass 2.

No Sample Left Behind

Science doesn't come in one size. Neither do our columns.

Whether you're working with precious microlitres or running industrial scale pilot studies, our qEV column range has you covered. From 150 µL to 100 mL and well into industrial scale, there's a column for every challenge.

Stated sample loading is the recommended volume for highest purity. All columns are reusable up to five times.

A Workflow for Every Application

General Research

Work with the purest EVs possible as you unravel their fate, function, and uptake, and explore strategies for clinical applications. The qEV Isolation platform delivers the reproducibility your research demands, from first isolation to final publication.

EV Diagnostics

Advance towards clinical validation without building a scaled workflow from scratch. Robotic liquid handling, bulk order discounts, cGMP-ready columns, and ISO 13485:2016 certification mean you can focus on the science, not the logistics.

Bioprocessing

Scale EV therapeutic and LNP production with confidence — from pilot study to cGMP-ready manufacturing. With custom column builds, automation, tangential flow filtration and 30+ years of bioprocessing expertise, the qEV Isolation platform is built for the full bioprocessing journey.

In Our Customers' Words

“We required a concentrated, high-quality EV isolate for our
in vivo animal studies, which we believe could be the foundation for future human translational work. The team optimized the process and purified the sample we provided, enabling us to proceed quickly to the next phase of our research. We are excited and look forward to leveraging Izon’s expertise to scale up the process for future clinical studies. Their collaborative support throughout this project has been invaluable, and I cannot thank them enough.”

Professor Shilpa Buch, PhD

University of Nebraska Medical Center

"Izon’s qEV columns offer a simple, effective and reproducible way of purifying EVs directly from biofluids or from EV enriched samples following differential centrifugation. During my PhD at Queensland University of Technology we used qEVoriginal columns (70 nm) for all of our EV preps from plasma and milk samples, prior to mass spectrometry-based proteomics and microRNA sequencing. Our group produced over 10 publications using these columns and continues to be satisfied with the results. I would highly recommend incorporating qEV columns as part of the EV enrichment workflow for any researchers struggling with EV yield and purity."

Natalie Turner, PhD

Postdoctoral Fellow at Scripps Research Institute

Start a Conversation About Your Research

Resources

Is it possible that the protein fractions will contain EVs?

Yes. Depending on the size of the resin pores, particles that are smaller than the pores will enter the resin and their progress through the column will be slowed. Hence, these particles may appear in later fractions. Columns have been optimised to reduce this as much as possible.

Is it possible to tailor fractions so that they correspond to a specific size profile?

No. The column length is not long enough to achieve this type of resolution effectively.

What type of blood collection tube should I use if I want to isolate EVs from blood products (plasma, serum, whole blood)?

There are many different types of blood collection tube available and the anticoagulant present in the tube can affect the functionality and quantity of EVs present in blood products. Anticoagulant choice is therefore dependent upon circumstance and application; to learn more, read this article about choosing a blood collection tube for EV research.

How do I determine which column I should use for my application?

Choose your qEV column size based on your sample loading volume. To choose your column type, you will need to consider whether you would prefer to prioritise particle recovery or particle purity. Visit the qEV series comparison page to compare qEV series. If you are still unsure, reach out to our friendly support staff for guidance.

What is the difference between the 20 nm, 35 nm and 70 nm columns?

qEV columns come in three series – 20 nm, 35 nm and 70 nm – named after the pore size of the resin used. Each series offers a different balance of particle recovery and purity: the 20 nm series maximises recovery, the 35 nm series balances recovery and purity, and the 70 nm series delivers the purest EV isolates with the highest level of lipoprotein depletion.

This trade-off comes down to size exclusion chromatography: larger particles like EVs pass around the resin beads and elute first, while proteins and other small molecules detour through the pores and trail behind. Larger pores trap more of these small molecules (leading to purer isolates); smaller pores trap fewer (leading to higher recovery, including smaller EVs). For more information, visit the qEV series comparison page or get in touch with the team for more guidance.